Results 101 to 110 of about 26,161 (209)

Abstracts

open access: yesMolecular Oncology, Volume 20, Issue S1, Page 1-692, August 2026.
Abstracts submitted to the ‘EACR 2026 Congress: Innovative Cancer Science’, from 08–11 June 2026 and accepted by the Congress Organising Committee are published in this Supplement of Molecular Oncology, an affiliated journal of the European Association for Cancer Research (EACR).
wiley   +1 more source

Clinical implications of imlifidase interference in antibody screening and transfusion management

open access: yesTransfusion, Volume 66, Issue 8, Page 1679-1685, August 2026.
Abstract Background Imlifidase has received conditional approval from the EMA for desensitizing deceased donor kidney transplant recipients. It works by cleaving IgG into F(ab′)2 and Fc fragments, thereby reducing the risk of antibody‐mediated rejection. However, its impact on diagnostic assays remains understudied. Case Report We present the case of a
Zgjim Osmani   +2 more
wiley   +1 more source

EGFR-Targeting IgG1 Antibody Enhances NK Cell-Mediated Tumor Killing in KRAS-Mutant Pancreatic Cancer. [PDF]

open access: yesMedComm (2020)
Xiao R   +10 more
europepmc   +1 more source

ADCC

open access: yesJapanese Journal of Clinical Immunology, 1978
openaire   +2 more sources

Enhanced Fc and complement activity of Fc-modified avelumab boosts anti-tumor activity but promotes NK cell fratricide. [PDF]

open access: yesClin Transl Immunology
Dobson LJ   +6 more
europepmc   +1 more source

2D NMR assessment of structural consistency and functional relationships in monoclonal antibodies. [PDF]

open access: yesMAbs
Wang L   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy